Ignite Creation Date:
2025-12-26 @ 5:23 PM
Ignite Modification Date:
2026-01-01 @ 2:32 AM
Study NCT ID:
NCT03089606
Status:
COMPLETED
Last Update Posted:
2023-11-15
First Post:
2017-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-24
First Submit QC Date:
None
Study First Post Date:
2017-03-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-01-28
Results First Submit QC Date:
None
Results First Post Date:
2022-07-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-07-14
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-11-13
Last Update Post Date:
2023-11-15
Last Update Post Date Type:
ACTUAL